Observational studyAnnals of hematology2024

Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.

Giuseppe Mele et al.PubMed ↗Publisher ↗

No numbers read from the abstract.